Cargando…

The mechanism of ions in pulmonary hypertension

Pulmonary hypertension（PH）is a kind of hemodynamic and pathophysiological state, in which the pulmonary artery pressure (PAP) rises above a certain threshold. The main pathological manifestation is pulmonary vasoconstriction and remodelling progressively. More and more studies have found that ions p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Guogu, Fu, Daiyan, Tian, Heshen, Dai, Aiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869166/ https://www.ncbi.nlm.nih.gov/pubmed/33614016 http://dx.doi.org/10.1177/2045894020987948

Ejemplares similares

Resistin-like molecule β acts as a mitogenic factor in hypoxic pulmonary hypertension via the Ca(2+)-dependent PI3K/Akt/mTOR and PKC/MAPK signaling pathways
por: Tian, Heshen, et al.
Publicado: (2021)

Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
por: Lambert, Mélanie, et al.
Publicado: (2018)

Epigenetic mechanisms of pulmonary hypertension
por: Kim, Gene H., et al.
Publicado: (2011)

Ion channels as convergence points in the pathology of pulmonary arterial hypertension
por: Jouen-Tachoire, Thibault R. H., et al.
Publicado: (2021)

The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension
por: Chen, Yi-Hang, et al.
Publicado: (2022)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Leopold, Jane A., et al.
Publicado: (2016)

Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension
por: Luna, R.C.P., et al.
Publicado: (2018)

Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review
por: Xiao, Ying, et al.
Publicado: (2020)

Obesity and Pulmonary Hypertension: A Review of Pathophysiologic Mechanisms
por: Friedman, Scott E., et al.
Publicado: (2012)

The mechanism of programmed death and endoplasmic reticulum stress in pulmonary hypertension
por: Sun, Yang, et al.
Publicado: (2023)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension
por: Yu, Zhijie, et al.
Publicado: (2022)

Advanced pulmonary arterial hypertension: mechanical support and lung transplantation
por: Bartolome, Sonja, et al.
Publicado: (2017)

Etiopathogenetic Mechanisms of Pulmonary Hypertension in Sleep-Related Breathing Disorders
por: Adegunsoye, Ayodeji, et al.
Publicado: (2012)

The Molecular Genetics and Cellular Mechanisms Underlying Pulmonary Arterial Hypertension
por: Machado, Rajiv D.
Publicado: (2012)

Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease
por: Bisserier, Malik, et al.
Publicado: (2019)

Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension
por: Reyes-García, Jorge, et al.
Publicado: (2022)

Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension
por: Martin de Miguel, Irene, et al.
Publicado: (2023)

Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities
por: Zeng, Zuomei, et al.
Publicado: (2023)

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
por: Koudstaal, Thomas, et al.
Publicado: (2020)

Chloride Ions, Vascular Function and Hypertension
por: Goto, Kenichi, et al.
Publicado: (2022)

Mechanisms of disease: pulmonary arterial hypertension
por: Schermuly, Ralph T., et al.
Publicado: (2011)

Pulmonary Vascular Remodeling in Pulmonary Hypertension
por: Jia, Zhuangzhuang, et al.
Publicado: (2023)

Mechanism of herbal medicine on hypertensive nephropathy
por: Dong, Zhaocheng, et al.
Publicado: (2021)

Right Ventricle Remodeling in Chronic Thromboembolic Pulmonary Hypertension
por: Liu, Jixiang, et al.
Publicado: (2022)

Treprostinil for pulmonary hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2008)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Osteopontin in Pulmonary Hypertension
por: Mamazhakypov, Argen, et al.
Publicado: (2023)

Pulmonary hypertension complicating pulmonary sarcoidosis
por: Huitema, M. P., et al.
Publicado: (2016)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension
por: Hu, Cheng‐Jun, et al.
Publicado: (2018)

Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
por: Malenfant, Simon, et al.
Publicado: (2021)

Vasoconstrictor Mechanisms in Chronic Hypoxia-Induced Pulmonary Hypertension: Role of Oxidant Signaling
por: Yan, Simin, et al.
Publicado: (2020)

Adaptive and innate immune mechanisms in cardiac fibrosis complicating pulmonary arterial hypertension
por: Siamwala, Jamila H., et al.
Publicado: (2020)

Apelin and pulmonary hypertension
por: Andersen, Charlotte U., et al.
Publicado: (2011)

Treatment of pulmonary hypertension
por: Patel, Rajendrakumar, et al.
Publicado: (2012)

Endoplasmic reticulum stress and pulmonary hypertension
por: Hu, Yanan, et al.
Publicado: (2020)

Pulmonary hypertension
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ieffnd8r0snqgeke3f0gauvkjr